Psoriasis Research Today is a free monthly online journal that collates and summarizes the latest research about Psoriasis, including details on treatment, prevention, medication, causes.

Volume 3 (2006), Issue 5 (May)

1. PSORS1: linking genetics and immunology.
   J Invest Dermatol, 126(6): 1205-6. [Abstract] [Full-text]
2. Carbazole is a naturally occurring inhibitor of angiogenesis and inflammation isolated from antipsoriatic coal tar.
   J Invest Dermatol, 126(6): 1396-402. [Abstract] [Full-text]
3. Photoadaptation during narrowband ultraviolet-B therapy is independent of skin type: a study of 352 patients.
   J Invest Dermatol, 126(6): 1256-63. [Abstract] [Full-text]
4. Use of alefacept and etanercept in 3 patients whose psoriasis failed to respond to etanercept.
   J Am Acad Dermatol, 54(6): 1099-101. [Abstract] [Full-text]
5. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study.
   J Am Acad Dermatol, 54(6): 1013-8. [Abstract] [Full-text]
6. Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
   J Am Acad Dermatol, 54(6): 1003-12. [Abstract] [Full-text]
7. Altered keratin 17 peptide ligands inhibit in vitro proliferation of keratinocytes and T cells isolated from patients with psoriasis.
   J Am Acad Dermatol, 54(6): 992-1002. [Abstract] [Full-text]
8. Development and reliability testing of a standardized questionnaire to assess psoriasis phenotype.
   J Am Acad Dermatol, 54(6): 987.e1-14. [Abstract] [Full-text]

© 2004-2008 Psoriasis Research Today. All Rights Reserved.